Freed From Pfizer, Capsugel May Find More Market Opportunities
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal heightens attention Pfizer is attracting from the investment community, already anticipating divestments outside the firm's innovative core pharma business.